Repligen (NASDAQ:RGEN) Downgraded by StockNews.com to Sell
StockNews.com cut shares of Repligen (NASDAQ:RGEN – Free Report) from a hold rating to a sell rating in a research note released on Friday morning. A number of other equities research analysts also recently weighed in on RGEN. JPMorgan Chase & Co. lifted their price target on shares of Repligen from $190.00 to $200.00 and […]
StockNews.com cut shares of Repligen (NASDAQ:RGEN – Free Report) from a hold rating to a sell rating in a research note released on Friday morning. A number of other equities research analysts also recently weighed in on RGEN. JPMorgan Chase & Co. lifted their price target on shares of Repligen from $190.00 to $200.00 and […]
